4//SEC Filing
Tsai Larry 4
Accession 0001209191-18-004654
CIK 0001373707other
Filed
Jan 18, 7:00 PM ET
Accepted
Jan 19, 7:47 PM ET
Size
8.0 KB
Accession
0001209191-18-004654
Insider Transaction Report
Form 4
Tsai Larry
Chief Medical Officer
Transactions
- Award
Restricted Stock Unit
2018-01-17+40,000→ 40,000 total→ Common Stock (40,000 underlying) - Award
Employee Stock Option (Right to Buy)
2018-01-17+150,000→ 150,000 totalExercise: $6.24Exp: 2028-01-16→ Common Stock (150,000 underlying)
Footnotes (3)
- [F1]Each restricted stock unit represents a contingent right to receive one share of common stock of Tetraphase Pharmaceuticals, Inc. for no consideration.
- [F2]These restricted stock units shall be earned upon achievement of certain performance conditions and, if earned, shall vest on January 31, 2021.
- [F3]Vests as to 6.25% of the shares on 4/17/2018 and further vests as to an additional 6.25% of the original grant at the end of each successive three-month period thereafter until 1/17/2022.
Documents
Issuer
TETRAPHASE PHARMACEUTICALS INC
CIK 0001373707
Entity typeother
Related Parties
1- filerCIK 0001725973
Filing Metadata
- Form type
- 4
- Filed
- Jan 18, 7:00 PM ET
- Accepted
- Jan 19, 7:47 PM ET
- Size
- 8.0 KB